Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway
Co-founder and CEO Mike Romanos steps down after six years to take up role of Associate Dean of Enterprise in the Faculty of Medicine at Imperial College Tim Sharpington, Microbiotica COO
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 22nd – 26th August 2022 .
The Cambridge-born start-up, which has recently closed a $15 million (£12.45 million) seed funding round (led by Ahren Innovation Capital with participation from Amadeus Capital, OMX Ventures and General Inception) to commercialise its technology, is taking 1,993 sq ft of space within the Park’s Science Village .
Chesterford Research Park has announced that Constructive Bio has joined the Park’s highly regarded multi-occupier R&D building, Science Village. The Cambridge-born start-up, which has recently closed a $15 million (£12.45 million) seed funding round (led by Ahren Innovation Capital with participation from Amadeus .